Recent advances in tumor biology and targeted therapies have led to clinical trials assessing treatment efficacy in multiple patient populations or subgroups using a master protocol [1]. These can lead to efficiency gains by testing several statistical hypotheses in the same clinical trial.
No takes yet. Share an insight, caveat, or question.
Stallard et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: